‘Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients’-Reference-Cited by-同舟云学术

‘Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients’

Published:2016-08-09 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Pérez-Sánchez C.,Aguirre M. A.,Ruiz-Limón P.,Barbarroja N.,Jiménez-Gómez Y.,de la Rosa I. Arias,Rodriguez-Ariza A.,Collantes-Estévez E.,Segui P.,Velasco F.,Cuadrado M. J.,Teruel R.,González-Conejero R.,Martínez C.,López-Pedrera Ch.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep31375.pdf

Reference60 articles.

1. Ames, P. R. et al. Atherosclerosis in thrombotic primary antiphospholipid syndrome. J. Thromb Haemost. 7, 537–542 (2009).

2. Alves, J. D. & Grima, B. Oxidative stress in systemic lupus erythematosus and antiphospholipid syndrome: a gateway to atherosclerosis. Curr. Rheumatol Rep. 5, 383–390 (2003).

3. Perez-Sanchez, C. et al. Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment. Blood 119, 5859–5870 (2012).

4. Pierangeli, S. S. et al. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 99, 1997–2002 (1999).

5. Meroni, P. L. et al. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J. Autoimmun. 15, 237–240 (2000).

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New advances in genomics and epigenetics in antiphospholipid syndrome;Rheumatology;2024-02-01

2. Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS);International Journal of Molecular Sciences;2023-07-18

3. High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome;Frontiers in Immunology;2023-05-19

4. Post-transcriptional control of haemostatic genes: mechanisms and emerging therapeutic concepts in thrombo-inflammatory disorders;Cardiovascular Research;2023-03-21

5. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms;International Journal of Molecular Sciences;2023-02-06